BE859819A - 1-(5-(phenyl substitue)-2-oxazolyl) methylene) amino)-2,4-imidazolidinediones - Google Patents

1-(5-(phenyl substitue)-2-oxazolyl) methylene) amino)-2,4-imidazolidinediones

Info

Publication number
BE859819A
BE859819A BE181820A BE181820A BE859819A BE 859819 A BE859819 A BE 859819A BE 181820 A BE181820 A BE 181820A BE 181820 A BE181820 A BE 181820A BE 859819 A BE859819 A BE 859819A
Authority
BE
Belgium
Prior art keywords
imidazolidinediones
oxazolyl
methylene
amino
phenyl substitute
Prior art date
Application number
BE181820A
Other languages
English (en)
French (fr)
Original Assignee
Morton Norwich Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morton Norwich Products Inc filed Critical Morton Norwich Products Inc
Publication of BE859819A publication Critical patent/BE859819A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE181820A 1976-10-18 1977-10-17 1-(5-(phenyl substitue)-2-oxazolyl) methylene) amino)-2,4-imidazolidinediones BE859819A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/733,296 US4049650A (en) 1976-10-18 1976-10-18 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones

Publications (1)

Publication Number Publication Date
BE859819A true BE859819A (fr) 1978-04-17

Family

ID=24947035

Family Applications (1)

Application Number Title Priority Date Filing Date
BE181820A BE859819A (fr) 1976-10-18 1977-10-17 1-(5-(phenyl substitue)-2-oxazolyl) methylene) amino)-2,4-imidazolidinediones

Country Status (14)

Country Link
US (1) US4049650A (nl)
JP (1) JPS5350167A (nl)
AU (1) AU505351B2 (nl)
BE (1) BE859819A (nl)
CA (1) CA1084510A (nl)
CH (1) CH629800A5 (nl)
DE (1) DE2746550A1 (nl)
ES (1) ES463297A1 (nl)
FR (1) FR2367763A1 (nl)
GB (1) GB1530770A (nl)
MX (1) MX5011E (nl)
NL (1) NL7711416A (nl)
SE (1) SE435382B (nl)
ZA (1) ZA775228B (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657559A1 (de) * 1976-12-18 1978-06-22 Bayer Ag Dioxopiperazinderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und als zwischenprodukte fuer beta-lactamantibiotika
US4128711A (en) * 1977-10-06 1978-12-05 Morton-Norwich Products, Inc. 1-[[1H-Pyrrol-2-ylmethylene]amino]-2,4-imidazolidinedione
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US4861790A (en) * 1987-10-28 1989-08-29 Norwich Eaton Pharmaceuticals, Inc. Use of azumolene for the treatment of malignant hyperthermia
WO2007145203A1 (ja) * 2006-06-13 2007-12-21 Daiichi Fine Chemical Co., Ltd. 光学活性2-アミノ-1-(4-フルオロフェニル)エタノール
IN2012DN02632A (nl) 2009-09-30 2015-09-04 Shiseido Co Ltd
HUP1300720A2 (hu) * 2013-12-12 2015-06-29 Univ Szegedi Gyógyászati készítmények sebgyógyulás elõsegítésére

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones
DE2106298A1 (nl) * 1971-02-10 1972-10-12
US3803136A (en) * 1972-08-23 1974-04-09 Morton Norwich Products Inc 5-hydroxy-1-((5-(substituted phenyl)furfurylidene)amino)hydrantoins
US3843636A (en) * 1974-01-25 1974-10-22 Morton Norwich Products Inc 1-(5-(p-methoxyphenyl)furfurylidene)amino)hydantoin
US4001222A (en) * 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof

Also Published As

Publication number Publication date
JPS5350167A (en) 1978-05-08
ZA775228B (en) 1979-04-25
US4049650A (en) 1977-09-20
NL7711416A (nl) 1978-04-20
AU505351B2 (en) 1979-11-15
SE435382B (sv) 1984-09-24
FR2367763B1 (nl) 1980-06-27
AU2803677A (en) 1979-02-22
DE2746550A1 (de) 1978-04-20
FR2367763A1 (fr) 1978-05-12
CH629800A5 (de) 1982-05-14
DE2746550C2 (nl) 1987-10-15
ES463297A1 (es) 1978-11-16
CA1084510A (en) 1980-08-26
JPS6225148B2 (nl) 1987-06-01
MX5011E (es) 1983-02-16
GB1530770A (en) 1978-11-01
SE7710086L (sv) 1978-04-19

Similar Documents

Publication Publication Date Title
NL7709744A (nl) Heterocyclische fenylethers en herbiciden, die deze bevatten.
NL7613735A (nl) Zeefvat.
NO770068L (no) S¦testoff.
NL7700579A (nl) Fotopolymeriseerbare massa.
NL7700033A (nl) 1-(gesubstitueerd amino)alkanoyl-2-(dibenzoxa- zepine-10-carbonyl)hydrazinen en derivaten daar- van.
BE852252A (fr) Nouveaux 5-(1,1-diphenyl-3-(5 ou 6-hydroxy ou-alcanoyloxy inferieur-2-aza-2-bicyclo(2,2,2)octoyl)propyl)-2-alkyl)1,3,4-oxodiazoles
OA05109A (fr) Nouvelles 1-(benzoyl substitué)-3-(pyrazinyl substitué)urée.
ATA758477A (de) Giess- bzw. spritzgiessform
BE859819A (fr) 1-(5-(phenyl substitue)-2-oxazolyl) methylene) amino)-2,4-imidazolidinediones
IT8123176A0 (it) Ossazolidin-2,4-dioni 5-sostituiti ipoglicemizzanti.
BE850239A (fr) Nouveaux triazolyl-0,n-acetals acyles
NL7709070A (nl) Trilmachine.
NL7704425A (nl) 1,3-dihydro-heteroarylspiro (isobenzofuranen).
DK326377A (da) Fremgangsmade til fremstilling af n-(1i-allyl-2i-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamid
BE847242A (fr) 3-(aminoacyl)-1-(5-(phenyl substitue)furfurylidene)-amino hydantoines,
NO147265C (no) Tegnesjikt for plastfolier.
DK21177A (da) 1-lavere alkyl-4,5-dihydro-5-phenyl-2-lavere alkoxycarbonylaminoimidazoler og substituerede phenylderivater deraf
DK405484A (da) N-(substituerede)-5-(substitueret-phenyl)-1,3-oxazolidiner. herbicidmodgifte
NO148047C (no) Digitalt styrt oscillator.
NL7701615A (nl) Spuitgietvorm.
NO803890L (no) Nye oxazoliner.
DK221177A (da) Fremgangsmade til fremstilling af n,n-dimetyl-3-(4-bromfenyl)-3-(3-pyridyl)-allylamindihydroklorid-monohydrat
PL199145A1 (pl) Sposob wytwarzania nowych zwiazkow pirymido(1,2a)heterocyklicznych
NO811521L (no) Meis for ryggsekk.
NL7711313A (nl) Trilvoedingsinrichting.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: NORWICH EATON PHARMACEUTICALS INC.

Effective date: 19921031